|
|
|
|
|
|
|
| Liquid-based
Pap Filtration &/or Enrichment |
| |
|
| As with so many clinical laboratory and pathology issues, details
of processes are not revealed or dwelt upon in the print or internet
media. Yet, we think they are often of great interest & importance
to those expertly charged with the responsibility to make decisions
as to choice of technique for use in patient screening and diagnosis. [liquid-
based (SurePath vs. ThinPrep) vendor methods compared]. [TriPath's
excellent & brief visual of PrepStain process for SurePath] |
How gradient enrichment works:
The SurePath collection device "head" is
dislodged into the transport fluid, and this 100% sample is transported
to the lab. About 80% of the ethanol-fixed SurePath (does
not distort the cells) thoroughly-homogenized sample volume (homogenized
cellularity from thetotally submitted collection-device end...cellularity
within sample fluidand mechanically dislodged from the
components of the collection device) is molecularly "strained".
Straining happens as differential centrifugation (x2) drives proper
density cells (the gradient fluid is said to be formulated
to especially favor malignant & benign epithelial cells,
regardless of size) through a density-gradient-barrier watery
fluid to form a "cleansed" proper-density cellular-concentrate "centrifugation
pellet". Too-little-density material (mucous & mucous
threads, tumor diathesis protein & fibrin, RBC membranes & platelet
clumps, & at least 50% of polys) fails to move through
the gradient fluid. Material that is dense enough but small (polys & Trich.)
to very small (bacteria) gets stratified within the 3cm. of gradient
fluid layer and partly diluted away. Excess sample after the "soft
spin" straining is pipetted & disposed of and the remaining
sample "hard spin" centrifuged to compact the strained/sifted
sample pellet. All gradient-fluid excess is then rapidly poured
off. The pellet is then resuspended & additionally homogenized;
an aliquot of this homogenate is placed into a disposable "settling
chamber" temporarily affixed to the surface of the diagnostic
positively "charged" slide. The charge draws a representative
population of (all cells...epithelia, inflammatory, & organisms...are
negatively charged) cells tightly (but without distortion) to
the slide surface to form a thin and uniform layer of enough negatively
charged cells to balance the positively charged slide. Cells do
not compete with mucous, protein, platelet clumps, RBC membrane
clumps, or excessive polys for space on the slide. Slide is then
stained for screening & diagnostic interpretation. [We
use "charged" slides in surgical pathology all of the
time to assure better "sticking" of the specimen section
to the slide through the sometimes violent staining process (especially
in IHC antigen retrieval maneuvers).]
How membrane filtration works:
A portion of the homogenized methanol-fixed
ThinPrep (methanol distorts cells by "rounding" them, & methanol "clots" sample
mucous) sample is swished into the collection container
from the collection device and gotten to the lab. Part of this
partial sample volume is "strained" by a suction vacuum
through a cloggable fixed-pore-size thin mechanical membrane until
a negative-pressure vacuum sensor detects that membrane "clogging" has
occurred...implying that a proper & possibly-concentrated cell-layer
has collected on the filter membrane surface (including
clotted mucous, protein, blood, and excess polys) mixed
with everything larger than the pores in the barrier filter. The
more densely mucoid and particulate the sample is, the quicker
membrane clogging occurs (quick clogging means less suspensate
fluid strained for abnormal epithelial cells). With that
thin cell-material layer in place on the filter, the filter is
slapped against a diagnostic slide (it can be a charged
slide) to leave a cellular monolayer "touch prep" on
the slide. The problematic thing here is that the system has no
way of knowing whether the vacuum sensor is triggered to stop suction
because of a properly cellular surface clogging or due to a heavy
component of debris and/or clotted mucous. Slide is then stained
for screening & diagnosis. |
Methods compared
| |
SurePath
|
ThinPrep
|
| filter type |
in depth |
surface |
| separation |
by cell or particle size & density, by liquid density gradient |
by cell or particle size, via fixed filter pore size |
| force |
differential centrifugation of cells of greater density through the
density gradient liquid |
by suction of sample liquid & small matter through pores |
| filtration stages |
multistage within one system |
single stage within one system |
| presents all sample removed from cervix? |
yes |
no |
| character of sample aliquot on slide |
always homogenized true enriched concentrate; residual can
be used for HPV & other tests |
possibly concentrated homogenate; residual can be used for
HPV & other tests |
| representativeness of cell layer on slide |
concentrate...truly representing cells obtained |
uncertain because filter clogging triggers the end of the
filtration process at various times...sooner when sample is rich in
pore-clogging extraneous debris |
|
| (initial posting 12/3/04; latest addition 27 March 2005) |
|
|
© Copyright
1999 - 2006, all rights reserved, Pathology Associates Of Lexington,
P.A. |
| |